header logo
PUBLISHED
Oct 14, 2024
WORDS
Dan Russell
Pharma must embrace purpose – for both social impact and business growth
Pharmaceutical brands often struggle to communicate their merits, says Dan Russell of Revolt. But, there’s a lot of upside in effectively explaining the work they do.
Read the original article on The Drum
The key to doing purpose properly is to ensure that it pays back. This means helping brands and businesses to grow through the way they tackle the problems of people and the planet. In health, that’s across the entire spectrum – from pharmaceuticals and health tech to consumer health. Brands are doing this well across consumer health and even in health tech, too. But, when it comes to pharma, it’s a very different ball game.

Most pharma companies have a corporate purpose, and most tend to be about changing, improving, or extending people’s lives – through reimagining medicine, innovation, or pushing the boundaries of science.

The question is, do these companies really live and breathe these statements beyond the words on their website? The opportunity here is to take that purpose and give it real meaning through every pillar of the business – not just understanding what it means for R&D or clinical studies, but also how it informs things like recruitment.
PHARMA’s STRUGGLE
So why do pharma brands struggle? Pharma is inherently purposeful, but it’s apologetic about creating drugs for profit. This is strange as it’s really no different from selling tea bags or fizzy drinks – they’re all businesses that exist to make money. The only real difference is that pharma products improve and save lives. 

Historically, the pharma industry has been very driven by price, so profit over purpose. This has made it harder for pharma companies to shout about ‘doing good’ as they’ve feared being called out. This fear does not just affect pharma. Companies in all categories make mistakes, but not all know how to own them and move past them.

Most pharma relationships are between brands and doctors. It’s then down to the doctors to act as the intermediaries between brands and patients. Compared with other categories, this creates another layer of communications, as pharma brands need to talk to both doctors and consumers. This additional layer of complexity has made it harder for pharma companies that have a people-focused purpose. 

Patients are at the heart of most pharma companies’ purpose statements, and the industry is clear that it needs to put them first in everything. But pharma congresses and clinical seem to be more brand-led than people-led. Pharma brands must start having direct relationships with consumers, allowing them to be real partners in what they do. This will bring pharma brands in line with today’s expectations and provide real differentiation from the competition.
BEYOND THE PILL
There are a lot of opportunities for pharma brands looking to use their scale and influence to make a positive impact on the world, while also growing the bottom line. As we outlined in our recent Health Report, moving from a focus on treating patients when they’re sick to looking after the whole person – with activities focused on health and wellness – is the best way to set up pharma and all other health brands. We call this ‘the new era of healthcare’. 

In this new era, we need to go ‘beyond the pill’ and think more broadly about how to advance health equity, improve provider experiences, diversify clinical trials, close education gaps, improve population health, and enhance patient experiences. 

Environmental, social, and governance (ESG) reporting is an increasingly critical tool within the pharma industry that links directly with corporate purpose. There is a growing trend towards greater transparency and accountability, driven by regulatory pressures, investor demands, and societal expectations. This presents an opportunity to identify and communicate key focus areas and overcome false barriers to driving value on those impact investments.

Revolt’s upcoming report – ‘The Cost of Silence’ – shows that pharma has one of the strongest correlations between reputational performance and the degree to which companies are perceived as sustainable, showing that those companies that take action today will benefit tomorrow.

Doing purpose properly in pharma might be a different ball game, but for those able to give purpose real meaning, the opportunity to make a positive impact and translate that into growth is enormous.
Related
Your Cookie Settings
By clicking 'Accept All Cookies', you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts.